Adamas: Supernus Pharmaceuticals Acquires Adamas Pharmaceuticals
ROCKVILLE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) - Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) today announced that it has successfully completed... Read MoreThe post Supernus Pharmaceuticals Acquires Adamas Pharmaceuticals appeared first on citybiz.
Read full article »
CEO
Adamas is a California-based pharmaceutical company that develops and commercializes therapies for the treatment of neurological diseases.
Read more